Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 36 Show results per page	View Search Criteria \| Help With Results

Last Modified: 4/29/2008 First Published: 12/16/2005


1.		Phase II/III Randomized Pilot Study of Androgen Suppression (AS) Alone Versus AS in Varying Combinations With Zoledronate, Docetaxel, Prednisolone, and/or Celecoxib in Patients With Locally Advanced or Metastatic Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				Not specified				Other				MRC-STAMPEDE EU-205102, MRC-PR08, ISRCTN78818544, EUDRACT-2004-000193-31, NCT00268476

Last Modified: 5/27/2008 First Published: 3/17/2006


2.		Phase III Randomized Study of Celecoxib for Prevention of Capecitabine-Induced Palmar/Plantar Syndrome in Patients With Metastatic Breast or Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				18 and over				NCI				MDA-CCC-0326 MDA-2005-0328, NCT00305643


3.		Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Approved-not yet active				18 and over				Other				tasmc-05-na-05160-ctil NCT00295035


4.		Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Biomarker/Laboratory analysis, Treatment				Active				18 and over				Other				SLCSG0501 NCT00300729


5.		Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Other				TASMC-07-NA-132-CTIL NCT00486460


6.		Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				Other				3c-03-19 NCT00159484


7.		A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				Other				NP01/07/03 NCT00212108


8.		Celebrex With Preoperative Chemoradiation - Rectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				Other				UHN REB 02-0130-C Ontario Cancer ResearchNetwork, NCT00188565

Last Modified: 8/30/2006 First Published: 7/23/2006


9.		Phase I/II Study of Celecoxib in Patients With Resectable Head and Neck Squamous Cell Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Biomarker/Laboratory analysis, Treatment				Active				18 and over				Other				CHUV-CEPO-161-05 EU-20627, NCT00357617


10.		Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Biomarker/Laboratory analysis, Prevention				Active				18 and over				Other				0405-2006 NCT00400374

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute